Kabra Drugs share news, announcements and annual reports
BSE: 524322Pharmaceuticals & BiotechnologySmall Cap
Kabra Drugs Ltd · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jul 1993
Last close ₹15.72down ₹0.54 (3.32%)
Share price at the BSE close on 29 Oct 2026. Previous close ₹16.26.
29 Oct: open ₹15.76, high ₹16.60, low ₹15.50
52-week range of traded prices to 29 Oct 2026
₹15.30Low, 28 Oct 2026₹35.52High, 11 Feb 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹37 Cr3,225th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 4.91
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 1.26
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 28.0%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 28.4%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.01
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 52,888
Kabra Drugs shareholder meetings
64 filed, newest first. Page 1 of 2.
Oct 2026
1 Oct · Meeting
Sep 2026
30 Sep · Meeting
7 Sep · Meeting
3 Sep · Meeting
Jun 2026
12 Jun · Meeting
12 Jun · Meeting
May 2026
8 May · Meeting
Dec 2025
27 Dec · Meeting
26 Dec · Meeting
Oct 2025
1 Oct · Meeting
Sep 2025
30 Sep · Meeting
6 Sep · Meeting
3 Sep · Meeting
Jan 2025
3 Jan · Meeting
2 Jan · Meeting
Dec 2024
Oct 2024
14 Oct · Meeting
1 Oct · Meeting
Sep 2024
30 Sep · Meeting
4 Sep · Meeting
2 Sep · Meeting
Feb 2024
19 Feb · Meeting
17 Feb · Meeting
Jan 2024
24 Jan · Meeting
Oct 2023
14 Oct · Meeting
Sep 2023
9 Sep · Meeting
Oct 2022
Sep 2022
30 Sep · Meeting
Oct 2021
Sep 2021
30 Sep · Meeting
8 Sep · Meeting
Oct 2020
Sep 2020
30 Sep · Meeting
7 Sep · Meeting
Oct 2019
Sep 2019
30 Sep · Meeting
10 Sep · Meeting
Aug 2018
13 Aug · Meeting
11 Aug · Meeting
Jul 2018
19 Jul · Meeting
Sep 2017
30 Sep · Meeting